Yanagida, Masatoshi <br/><br/>
Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.  [electronic resource] 

 -  Oncogene  Jun 2005 
 - 4477-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1208675  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Core Binding Factor Alpha 2 Subunit<br/>DNA Transposable Elements<br/>DNA-Binding Proteins--genetics<br/>Disease Models, Animal<br/>Erythroid-Specific DNA-Binding Factors<br/>GATA1 Transcription Factor<br/>Gene Dosage<br/>Gene Expression Regulation, Leukemic<br/>Humans<br/>Integrin beta3--genetics<br/>Leukemia, Myeloid--genetics<br/>Leukocytes--immunology<br/>Mice<br/>Mice, Mutant Strains<br/>Mice, Transgenic<br/>Promoter Regions, Genetic<br/>Proto-Oncogene Proteins--genetics<br/>Retroviridae--genetics<br/>Transcription Factors--genetics